Clinical neurorestorative progress in traumatic brain injury

Which of these therapies mentioned can also be used in stroke? Does your doctor know anything about this?
http://www.dovepress.com/articles.php?article_id=20957

Authors Huang H, Chen L, Huang H
Published Date March 2015 Volume 2015:3 Pages 57—62
DOI http://dx.doi.org/10.2147/JN.S74486
Received 30 September 2014, Accepted 26 November 2014, Published 20 March 2015
Approved for publication by Prof. Dr. Hari Shanker Sharma

Huiling Huang,¹ Lin Chen,^2,3 Hongyun Huang<sup>4–6

1</sup>Tianjin Key Laboratory of Cerebral Vascular and Neurodegenerative Diseases, Tianjin Huanhu Hospital, Tianjin Neurosurgical Institute, Tianjin, People's Republic of China; ²Medical Center, Tsinghua University, Beijing, People's Republic of China; ³Tsinghua University Yuquan Hospital, Beijing, People's Republic of China; ⁴General Hospital of Chinese people's Armed Police Forces, ⁵Beijing Rehabilitation Hospital of Capital Medical University, Beijing, People's Republic of China; ⁶Beijing Hongtianji Neuroscience Academy, Beijing, People's Republic of China

Abstract: Traumatic brain injury (TBI) is a leading cause of death and disability from trauma to the central nervous system. Besides the surgical interventions and symptomatic management, the conventional therapies for TBI and its sequelae are still limited. Recently emerging evidence suggests that some neurorestorative treatments appear to have a potential therapeutic role for TBI and improving the patient's quality of life. The current clinical neurorestorative strategies available in TBI include pharmacological treatments (recombinant human interleukin-1 receptor antagonist, amantadine, lithium, and valproate), the neuromodulation treatments (repetitive transcranial magnetic stimulation, transcranial direct current stimulation, and low-level laser therapy), cell transplantation (bone marrow stromal cells and umbilical cord stromal cells), and combined neurorehabilitation. In this review, we summarize the recent clinical neurorestorative progress in the management of neurodegeneration as well as cognitive and motor deficits after TBI; indeed further clinical trials are required to provide more robust evidence.